Researchers are using AI to predict Alzheimer's disease seven years before clinical diagnosis.
IBM Research and Pfizer have developed a new AI model that uses quick speech tests to help predict the onset of the disease in healthy people
The research team hopes that going forward, using speech and digital biomarkers will allow for targeted recruitment for therapies and intervention. This may actually improve the odds of success for therapies in the future.
Further data is needed to train the AI and validate results however the work is highly promising.